334 related articles for article (PubMed ID: 31669585)
21. Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.
Lin YP; Li L; Zhang F; Linhardt RJ
Microbiology (Reading); 2017 Dec; 163(12):1759-1766. PubMed ID: 29116038
[TBL] [Abstract][Full Text] [Related]
22. Structural rationale for the affinity of pico- and femtomolar transition state analogues of Escherichia coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase.
Lee JE; Singh V; Evans GB; Tyler PC; Furneaux RH; Cornell KA; Riscoe MK; Schramm VL; Howell PL
J Biol Chem; 2005 May; 280(18):18274-82. PubMed ID: 15746096
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic treatment of animals infected with Borrelia burgdorferi.
Wormser GP; Schwartz I
Clin Microbiol Rev; 2009 Jul; 22(3):387-95. PubMed ID: 19597005
[TBL] [Abstract][Full Text] [Related]
24. Salmonella enterica MTAN at 1.36 Å resolution: a structure-based design of tailored transition state analogs.
Haapalainen AM; Thomas K; Tyler PC; Evans GB; Almo SC; Schramm VL
Structure; 2013 Jun; 21(6):963-74. PubMed ID: 23685211
[TBL] [Abstract][Full Text] [Related]
25. Structure of Escherichia coli 5'-methylthioadenosine/ S-adenosylhomocysteine nucleosidase inhibitor complexes provide insight into the conformational changes required for substrate binding and catalysis.
Lee JE; Cornell KA; Riscoe MK; Howell PL
J Biol Chem; 2003 Mar; 278(10):8761-70. PubMed ID: 12496243
[TBL] [Abstract][Full Text] [Related]
26. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
[TBL] [Abstract][Full Text] [Related]
27. Role of aggrecanase 1 in Lyme arthritis.
Behera AK; Hildebrand E; Szafranski J; Hung HH; Grodzinsky AJ; Lafyatis R; Koch AE; Kalish R; Perides G; Steere AC; Hu LT
Arthritis Rheum; 2006 Oct; 54(10):3319-29. PubMed ID: 17009305
[TBL] [Abstract][Full Text] [Related]
28. Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice.
Wormser GP; Daniels TJ; Bittker S; Cooper D; Wang G; Pavia CS
J Infect Dis; 2012 Mar; 205(6):991-4. PubMed ID: 21930606
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
Wagner B; Goodman LB; Rollins A; Freer HS
Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
[TBL] [Abstract][Full Text] [Related]
30. Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism.
Parveen N; Cornell KA
Mol Microbiol; 2011 Jan; 79(1):7-20. PubMed ID: 21166890
[TBL] [Abstract][Full Text] [Related]
31. Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.
Hunfeld KP; Kraiczy P; Kekoukh E; Schäfer V; Brade V
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():125-37. PubMed ID: 12141737
[TBL] [Abstract][Full Text] [Related]
32. Molecular determinants of substrate specificity in plant 5'-methylthioadenosine nucleosidases.
Siu KK; Lee JE; Sufrin JR; Moffatt BA; McMillan M; Cornell KA; Isom C; Howell PL
J Mol Biol; 2008 Apr; 378(1):112-28. PubMed ID: 18342331
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis.
Kannian P; McHugh G; Johnson BJ; Bacon RM; Glickstein LJ; Steere AC
Arthritis Rheum; 2007 Dec; 56(12):4216-25. PubMed ID: 18050219
[TBL] [Abstract][Full Text] [Related]
34. Functional outcomes in patients with Borrelia burgdorferi reinfection.
Jares TM; Mathiason MA; Kowalski TJ
Ticks Tick Borne Dis; 2014 Feb; 5(1):58-62. PubMed ID: 24215678
[TBL] [Abstract][Full Text] [Related]
35. Detection of Bioluminescent Borrelia burgdorferi from In Vitro Cultivation and During Murine Infection.
Hyde JA; Skare JT
Methods Mol Biol; 2018; 1690():241-257. PubMed ID: 29032549
[TBL] [Abstract][Full Text] [Related]
36. Disruption of bbe02 by Insertion of a Luciferase Gene Increases Transformation Efficiency of Borrelia burgdorferi and Allows Live Imaging in Lyme Disease Susceptible C3H Mice.
Chan K; Alter L; Barthold SW; Parveen N
PLoS One; 2015; 10(6):e0129532. PubMed ID: 26069970
[TBL] [Abstract][Full Text] [Related]
37. [Borrelia burgdorferi--a unique bacterium].
Brorson Ø
Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2114-7. PubMed ID: 19855450
[No Abstract] [Full Text] [Related]
38. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi.
Horowitz RI; Murali K; Gaur G; Freeman PR; Sapi E
BMC Res Notes; 2020 Sep; 13(1):455. PubMed ID: 32993780
[TBL] [Abstract][Full Text] [Related]
39. Structural comparison of MTA phosphorylase and MTA/AdoHcy nucleosidase explains substrate preferences and identifies regions exploitable for inhibitor design.
Lee JE; Settembre EC; Cornell KA; Riscoe MK; Sufrin JR; Ealick SE; Howell PL
Biochemistry; 2004 May; 43(18):5159-69. PubMed ID: 15122881
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
